sawhney

Biotech company Ocular Therapeutix is imploding after announcing disappointing trial results (OCUL)

REUTERS/China Daily
Shares of $875 million biotech company Ocular Therapeutix were down as much as 30% in after hours trade on Monday after the company reported clinical trial results that disappointed. The company announced Monday that topline data for its lead drug candidate, a treatment for ocular inflammation following cataract surgery, met one of its two primary endpoints. The company said both endpoints needed […]